What are the symptoms of Human Herpesvirus 6 (HHV6) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Human Herpesvirus 6 (HHV-6) Infection

The primary symptoms of HHV-6 infection include fever, rash, confusion, encephalopathy, short-term memory loss, seizures, and insomnia, with manifestations varying significantly between primary infection in children and reactivation in immunocompromised adults. 1

Primary HHV-6 Infection

In Children

HHV-6 is primarily known for causing:

  • Fever (high)
  • Roseola infantum (characteristic rash that appears after fever subsides)
  • Febrile seizures
  • Most infections occur in healthy infants, with HHV-6B being the predominant variant 2

In Adults

Primary infection in adults is rare but can present as:

  • Mononucleosis-like illness
  • Fever
  • Rarely, severe disease including encephalitis 3

HHV-6 Reactivation in Immunocompromised Patients

Reactivation is most common in:

  • Hematopoietic stem cell transplant (HSCT) recipients
  • Solid organ transplant recipients
  • Other immunocompromised individuals

Common Symptoms of Reactivation

  • Fever
  • Rash
  • Encephalitis/encephalopathy
  • Bone marrow suppression (myelosuppression)
  • Delayed engraftment (particularly affecting platelets) 1

Neurological Manifestations (HHV-6 Encephalitis)

HHV-6 encephalitis typically presents with:

  • Confusion
  • Encephalopathy
  • Short-term memory loss
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • Seizures (particularly temporal lobe seizures)
  • Insomnia 1

In HSCT recipients, HHV-6 encephalitis often presents as post-transplant acute limbic encephalitis (PALE) with:

  • Disease onset typically 2-6 weeks post-transplantation
  • Memory defects and neuropsychological sequelae in 20-60% of cases
  • Potential mortality rate of up to 25% in HSCT recipients and up to 50% in cord blood recipients 1

Other Potential Manifestations

  • Pneumonitis
  • Hepatitis
  • Myelitis
  • Cerebellar ataxia 4
  • Headache
  • Delirium
  • Neurocognitive decline 1

Diagnostic Findings

Cerebrospinal Fluid (CSF)

  • HHV-6B DNA in CSF
  • Often unremarkable protein and cell counts
  • Mild protein elevation in some cases
  • Mild lymphocytic pleocytosis in some cases 1

Neuroimaging

  • MRI may be negative at disease onset
  • Changes in temporal lobe in approximately 60% of cases
  • Typically circumscribed, non-enhancing, hyperintense lesions in the medial temporal lobes (especially hippocampus and amygdala) 1
  • Lesions can also occur in other areas such as the midbrain 4

Risk Factors for Severe HHV-6 Disease

The highest risk is seen in:

  • Cord blood transplant recipients
  • T-cell depleted transplant recipients
  • HLA-mismatched unrelated donors
  • Haploidentical transplant recipients 1

Clinical Pitfalls and Caveats

  1. HHV-6 DNA can be found in CSF in patients without CNS symptoms, making interpretation challenging 1

  2. Chromosomally integrated HHV-6 (CIHHV-6) must be excluded when diagnosing HHV-6 encephalitis, as it can lead to false positive results 1

  3. HHV-6 encephalitis can be misdiagnosed as other forms of limbic encephalitis, as similar MRI findings can occur with other infectious agents 1

  4. Only one-third of HHV-6 encephalitis patients may present with the typical features of post-transplant acute limbic encephalitis 1

  5. Long-term neurological sequelae, including temporal lobe epilepsy in adults and cognitive regression in children, can occur even after successful treatment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Human herpesvirus 6 (HHV6) infection.

Indian journal of pediatrics, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.